A Phase IV, Open-label, Non-randomized, Clinical Trial to Evaluate the Safety of Self-administered ADASUVE® (Staccato Loxapine for Inhalation) in Agitated Patients Outside the Hospital Setting
Phase of Trial: Phase IV
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Loxapine (Primary)
- Indications Agitation
- Focus Adverse reactions
- Sponsors Ferrer
- 28 Mar 2017 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.
- 28 Mar 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Dec 2017.
- 28 Mar 2017 Status changed from not yet recruiting to recruiting.